Clinical Trials Directory

Trials / Terminated

TerminatedNCT03253224

Magnesium and Postoperative Pain

The Influence of Intraoperative Magnesium Sulfate Administration on Postoperative Pain After Total Knee Arthroplasty in Patients Sedated With Dexmedetomidine Under Spinal Anesthesia: A Randomized-controlled Trial

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
50 Years – 75 Years
Healthy volunteers
Not accepted

Summary

With ongoing advancements in healthcare leading to prolonged life expectancy, orthopedic surgeries are increasingly performed in elderly patients. Total knee arthroplasty, in particular, has been increasing with the growing demand for improved mobility and quality of life. Total knee arthroplasty is performed on patients with advanced and painful osteoarthritis of the knees, but it can result in moderate to severe postoperative pain during the recovery period. To relieve anxiety or stress during surgery under regional anesthesia, sedation can be provided. Dexmedetomidine is a sedative-analgesic agent acting as α2-adrenergic receptor agonist, and its analgesic effect has been well established in various procedures or surgeries. Magnesium has been reported to produce important analgesic effects including the suppression of neuropathic pain, potentiation of morphine analgesia, and attenuation of morphine tolerance. Although the exact mechanism is not yet fully understood, the analgesic properties of magnesium are believed to stem from regulation of calcium influx into the cell and antagonism of N-methyl-D-aspartate (NMDA) receptors in the central nervous system. In this study, investigators will evaluate the reducing effect of magnesium on the post-total knee arthroplasty pain in patients sedated with dexmedetomidine under spinal anesthesia.

Conditions

Interventions

TypeNameDescription
DRUGMagnesium SulfateMagnesium group receives magnesium sulfate (50 mg/kg) in 100 mL of normal saline over 15 min during induction of anesthesia, followed by a continuous magnesium sulfate infusion (15 mg/kg/h) until the end of surgery.
DRUGNormal salineNormal saline group receives the same volume of normal saline, administered according to the same method as in the magnesium group.

Timeline

Start date
2017-09-10
Primary completion
2018-03-29
Completion
2018-03-29
First posted
2017-08-17
Last updated
2018-04-18

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03253224. Inclusion in this directory is not an endorsement.